NVST
Envista Holdings Corp
NYSE · Healthcare · Medical - Equipment & Services · US
$23.19
+0.96%Year over year
Reported trailing growth
- Revenue
- +11.9%
- EBITDA
- +39.7%
- EBIT
- +80.7%
- EPS
- +87.5%
- Free cash flow
- -9.9%
- Operating cash flow
- +2.5%
Forward estimates
Based on analyst estimates
- Revenue
- +3.0%
- EBITDA
- +31.1%
- EPS
- +171.7%
Three-year CAGR
- Revenue
- +1.9%
- EBITDA
- -14.2%
- EBIT
- -10.9%
- Net income
- -42.2%
- EPS
- -42.3%
- Free cash flow
- +29.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026